# Metabolic Responses of Metformin and Genetic Polymorphisms of SLC22A1 Gene in PCOS

> **NCT05680805** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh** · enrollment: 100 (estimated)

## Conditions studied

- Polycystic Ovary Syndrome
- Metformin

## Interventions

- **DRUG:** Metformin Hydrochloride

## Key facts

- **NCT ID:** NCT05680805
- **Lead sponsor:** Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-05-27
- **Primary completion:** 2025-11-30
- **Final completion:** 2025-11-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05680805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05680805, "Metabolic Responses of Metformin and Genetic Polymorphisms of SLC22A1 Gene in PCOS". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05680805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*